243 related articles for article (PubMed ID: 8574719)
1. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
2. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
[TBL] [Abstract][Full Text] [Related]
3. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
[TBL] [Abstract][Full Text] [Related]
4. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
5. The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.
Schmidt C; Fels T; Baumeister B; Vetter H
Curr Med Res Opin; 1996; 13(7):417-25. PubMed ID: 8862941
[TBL] [Abstract][Full Text] [Related]
6. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Kreisel W; Wolf LM; Grotz W; Grieshaber M
Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen J; Bukhave K; Laursen LS; Lauritsen K
Agents Actions; 1992; Spec No():C37-46. PubMed ID: 1359745
[TBL] [Abstract][Full Text] [Related]
8. Increased prostaglandin E2 and leukotriene B4 synthesis in isolated colonic mucosal cells in inflammatory bowel disease. a preliminary report.
Baumeister B; Schmidt C; Helisch A; Kipnowski J
J Clin Gastroenterol; 1996 Mar; 22(2):117-20. PubMed ID: 8742650
[TBL] [Abstract][Full Text] [Related]
9. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
Sharon P; Stenson WF
Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
[TBL] [Abstract][Full Text] [Related]
10. Calcium modulates the synthesis of prostaglandin E2 in isolated colonic mucosal cells.
Schmidt C; Ramachers S; Baumeister B; Vetter H; Kipnowski J
Hepatogastroenterology; 1997; 44(13):84-9. PubMed ID: 9058125
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Lauritsen K
Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
[No Abstract] [Full Text] [Related]
12. Leukotriene B4 receptor levels and intracellular calcium signalling in polymorphonuclear leukocytes from patients with Crohn's disease.
Bouchelouche PN; Berild D; Nielsen OH; Elmgreen J; Poulsen HS
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):349-56. PubMed ID: 7600141
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic therapy for inflammatory bowel disease.
Hirschfeld S; Clearfield HR
Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
[TBL] [Abstract][Full Text] [Related]
14. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
[TBL] [Abstract][Full Text] [Related]
15. 5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.
Clerici C; Gentili G; Pellicciari R; Gresele P; Mezzasoma AM; Giansanti M; Clementi M; Bartoli G; Balò S; Modesto R; Aburbeh AG; Morelli O; Morelli A
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):385-90. PubMed ID: 9789134
[TBL] [Abstract][Full Text] [Related]
16. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
17. 15-HETE is the main eicosanoid formed by human colonic mucosa.
Zijlstra FJ; van Dijk AP; Wilson JH; van Riemsdijk-Overbeeke IC; Vincent JE; Ouwendijk RJ
Agents Actions; 1992; Spec No():C53-9. PubMed ID: 1442336
[TBL] [Abstract][Full Text] [Related]
18. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease.
Nikolaus S; Fölscn U; Schreiber S
Hepatogastroenterology; 2000; 47(31):71-82. PubMed ID: 10690587
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
20. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
Hillingsø J; Kjeldsen J; Laursen LS; Lauritsen K; von Spreckelsen S; Depré M; Friedman BS; Malmström K; Shingo S; Bukhave K
Clin Pharmacol Ther; 1995 Mar; 57(3):335-41. PubMed ID: 7697951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
